Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Allergan, Inc.    

ALLERGAN, INC.
Mes dernières consult.
Most popular
  Report  
SummaryNewsCalendarCompany 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Allergan, Inc. : Allergan Gets Subpoena From Government Over Lap-Band System

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/08/2012 | 12:11am CEST
   By Anjali Athavaley 
   Of  
 

Allergan Inc. (AGN) received a subpoena this month from the Department of Health and Human Services requesting documents related to the company's Lap-Band System for obesity, according to a filing.

Lap-Band is approved to help obese patients lose weight. It is inserted surgically through a small incision and placed at the top of the stomach. The inflatable band can be tightened or loosened to reduce or enlarge stomach capacity.

An Allergan spokeswoman declined to comment further.

Earlier this month, Allergan said its first-quarter earnings rose 45% on double-digit sales growth in its specialty-pharmaceuticals business. But sales in Allergan's obesity intervention category slipped 15.5% as high unemployment, lofty co-payments and rigid requirements from insurers pressured sales.

Last December, the U.S. Food and Drug Administration warned nine groups, mostly surgical centers in California, that if they continue misleading advertising for Lap-Band, they could face monetary penalties and have inventory seized. The FDA made no allegations against Allergan at the time.

Allergan shares were up fractionally to $93.79 in after-hours trading Monday. The stock is up nearly 7% so far this year.

-By Anjali Athavaley, Dow Jones Newswires; 212-416-4912; [email protected]

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ALLERGAN, INC.
2017Mylan defends chairman to ISS ahead of June 22 investor vote
RE
2017ALLERGAN : to Present New Data on Chronic Migraine at the American Headache Soci..
PU
2017FEATURED COMPANY NEWS - MYLAN LAUNCH : Generic Reclast® Injection and Generic Az..
AQ
2017U.S. state, local government lawsuits over opioids face uphill battle
RE
2017ALLERGAN : to Present Data from its Anti-Infectives Portfolio at ASM Microbe 201..
PU
2017ALLERGAN PLC : Entry into a Material Definitive Agreement, Other Events, Financi..
AQ
2017ALLERGAN PLC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2017ALLERGAN : Kristin Chenoweth Kicks Off 'Less Red, More You' Campaign To Launch R..
PU
2017ALLERGAN PLC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2017HEALTH CANADA APPROVES ALLERGAN PLC : AGN) IBS Drug Viberzi
AQ
More news
News from SeekingAlpha
2015MANNKIND : A Head Pain Gain Or A Pocket-Book Drain? 
2015Tracking Dan Loeb's Third Point Portfolio - Q1 2015 Update 
2015Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q1 2015 Update 
2015Time Warner Is A Buy - Cramer's Lightning Round (5/21/15) 
2015Tracking John Paulson's Paulson & Company Portfolio - Q1 2015 Update 
Chart ALLERGAN, INC.
Duration : Period :
Allergan, Inc. Technical Analysis Chart | US0184901025 | 4-Traders
Managers
NameTitle
Ambrose Robert Douglas Bailey Chief Executive Officer
Maria Teresa Hilado Chief Financial Officer
Raymond H. Diradoorian Executive VP-Global Technical Operations
Joann Bradley Investor Relations Contact
David Nakasone Investor Relations Contact
Sector and Competitors
1st jan.Capitalization (M$)
ALLERGAN, INC.0
JOHNSON & JOHNSON-9.23%340 239
PFIZER1.13%218 908
NOVARTIS-8.06%203 482
ROCHE HOLDING LTD.-11.08%192 055
MERCK AND COMPANY6.79%162 398